ORGO
NASDAQ
US
Organogenesis Holdings Inc. - Class A
$2,24
▼ $-0,07
(-3,03%)
Vol 507K
12
Skor Kualitas
ok
Pemeriksaan Mendalam
1/5
fail
Pendapatan ✗
Laba Bersih ✓
>IPO ✗
Kap. Pasar
$657.4M
P/E
654,1
ROE
0,3%
Margin
0,2%
D/E
0,86
Beta
1,50
52W
$3–$7
Konsensus Wall Street
7 analis · Apr 20263
Beli Kuat
3
Beli
1
Tahan
0
Jual
0
Jual Kuat
85,7%
Peringkat Beli
Grafik Harga
Saham Serupa
CLYM
Climb Bio Inc
$272.7M
RZLT
Rezolute Inc
$218.8M
OVID
Ovid Therapeutics Inc
$116.1M
FHTX
Foghorn Therapeutics Inc
$305.4M
NBP
NovaBridge Biosciences
$458.9M
AVXL
Anavex Life Sciences Corp
$318.1M
TARA
Protara Therapeutics Inc
$275.2M
CCCC
C4 Therapeutics Inc
$185.1M
ABEO
Abeona Therapeutics Inc
P/E 3,5
$285.6M
Pendapatan
Tingkat beat: 50,0%
Laporan Berikutnya
Mei 06, 2026
Estimasi EPS: $-0,30
| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Mar 2026 | $-0,30 | — | — |
| Des 2025 | $0,21 | $0,31 | +$0,10 |
| Sep 2025 | $0,06 | $0,15 | +$0,09 |
| Jun 2025 | $-0,06 | $-0,10 | $-0,04 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Pendapatan | — | $126.7M | $86.7M | $100.8M | $150.5M | $225.1M |
| Laba Bersih | — | $7.7M | -$18.8M | -$9.4M | $21.6M | $43.7M |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -2.4% | -2.4% | -2.4% | -2.4% | 0.3% | 0.3% |
| P/E (TTM) | — | — | — | — | 635.19 | 654.13 |
| Net Margin | -9.3% | -1.9% | -1.9% | -1.9% | 0.2% | 0.2% |
| Gross Margin | 72.6% | 74.6% | 74.6% | 74.6% | 74.5% | 74.5% |
| D/E Ratio | 0.36 | 0.36 | 0.36 | 0.36 | 0.86 | 0.86 |
| Current Ratio | 3.95 | 3.95 | 3.95 | 3.95 | 3.32 | 3.32 |
Rasio Utama
ROA (TTM)
0,2%
P/S (TTM)
1,41
P/B
1,0
EPS (TTM)
$0,00
CF/Share
$0,20
Pertumbuhan Pendapatan 3T
+1,0%
52W High
$7,08
52W Low
$2,61
$2,61
Rentang 52 Minggu
$7,08
Kesehatan Keuangan
Arus Kas Bebas
$34.8M
Utang Bersih
-$11.5M
Kas
$93.7M
Total Utang
$82.1M
Per tanggal Des 31, 2025
Як ORGO виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка ORGO vs аналоги Biotechnology
P/E
654,1
▲
3383%
di atas
rekan
(18,8)
vs Rekan
vs Industri
Undervalued
P/S
1,4
▼
89%
di bawah
rekan
(12,9)
vs Rekan
vs Industri
Undervalued
P/B
1,0
▼
58%
di bawah
rekan
(2,5)
vs Rekan
vs Industri
Undervalued
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(0,0%)
vs Rekan
vs Industri
Yield rendah
Прибутковість ORGO vs аналоги Biotechnology
ROE
0,3%
▲
100%
di atas
rekan
(-67,3%)
vs Rekan
vs Industri
Tingkat atas
Net margin
0,2%
▲
100%
di atas
rekan
(-286,8%)
vs Rekan
vs Industri
Di bawah rata-rata
Валова маржа
74,5%
▼
5%
di bawah
rekan
(78,6%)
vs Rekan
vs Industri
Lemah
ROA
0,2%
▲
100%
di atas
rekan
(-46,7%)
vs Rekan
vs Industri
Tingkat atas
Фінансове здоровʼя ORGO vs аналоги Biotechnology
D/E ratio
0,9
▼
0%
di bawah
rekan
(0,0)
vs Rekan
vs Industri
Sejajar
Поточна ліквідність
3,3
▼
25%
di bawah
rekan
(4,4)
vs Rekan
vs Industri
Likuiditas rendah
Beta
1,5
▲
54%
di atas
rekan
(1,0)
vs Rekan
vs Industri
Lebih volatil
Радар фундаменталів ORGO
ORGO
Median rekan
Industri
ORGO прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
ORGO vs аналоги: ключові метрики
Aktivitas Orang Dalam
NeutralPembelian
0
Penjualan
0
LEIBOWITZ ARTHUR S
Director · Mar 09
5000 shs
DRISCOLL MICHAEL JOSEPH
Director · Mar 09
10000 shs
KORFIN MICHELE ILENE
Director · Feb 18
48828 shs
DURAIBABU PRATHYUSHA
Director · Feb 18
48828 shs
FRANCISCO DAVID
Chief Financial Officer · Feb 18
238914 shs
FRANCISCO DAVID
Chief Financial Officer · Feb 18
239352 shs
DRISCOLL MICHAEL JOSEPH
Director · Feb 18
48828 shs
QUINTERO GILBERTO
Director · Feb 18
48828 shs
CAVORSI ROBERT
Officer · Feb 18
110204 shs
LUSTIG GARRETT
Director · Feb 18
48828 shs
Terakhir 90 hari
Pemegang Terbesar
Top 5: 28,66%Morgan Stanley
9,05%
$26.7M
Soleus Capital Management, …
7,76%
$22.9M
Assenagon Asset Management …
4,30%
$12.7M
Vanguard Group Inc
3,85%
$11.4M
Blackrock Inc.
3,70%
$10.9M
Per tanggal Des 31, 2025